These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28371958)

  • 1. [Diagnostic Accuracy of German Depression Screenings in Patients with Coronary Heart Disease].
    Tschorn M; Rieckmann N; Arolt V; Beer K; Haverkamp W; Martus P; Waltenberger J; Müller-Nordhorn J; Ströhle A
    Psychiatr Prax; 2019 Jan; 46(1):41-48. PubMed ID: 28371958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detecting depression in patients with coronary heart disease: a diagnostic evaluation of the PHQ-9 and HADS-D in primary care, findings from the UPBEAT-UK study.
    Haddad M; Walters P; Phillips R; Tsakok J; Williams P; Mann A; Tylee A
    PLoS One; 2013; 8(10):e78493. PubMed ID: 24130903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for depression in acute coronary syndrome patients: A comparison of Patient Health Questionnaire-9 versus Hospital Anxiety and Depression Scale-Depression.
    Yuan J; Ding R; Wang L; Sheng L; Li J; Hu D
    J Psychosom Res; 2019 Jun; 121():24-28. PubMed ID: 30928210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validity of the Hospital Anxiety and Depression Scale and Patient Health Questionnaire-9 to screen for depression in patients with coronary artery disease.
    Stafford L; Berk M; Jackson HJ
    Gen Hosp Psychiatry; 2007; 29(5):417-24. PubMed ID: 17888808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Hospital Anxiety and Depression Scale (HADS) and the 9-item Patient Health Questionnaire (PHQ-9) as screening instruments for depression in patients with cancer.
    Hartung TJ; Friedrich M; Johansen C; Wittchen HU; Faller H; Koch U; Brähler E; Härter M; Keller M; Schulz H; Wegscheider K; Weis J; Mehnert A
    Cancer; 2017 Nov; 123(21):4236-4243. PubMed ID: 28654189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validating screening tools for depression in stroke and transient ischemic attack patients.
    Prisnie JC; Fiest KM; Coutts SB; Patten SB; Atta CA; Blaikie L; Bulloch AG; Demchuk A; Hill MD; Smith EE; Jetté N
    Int J Psychiatry Med; 2016 Apr; 51(3):262-77. PubMed ID: 27284119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of two self-rating scales to detect depression: HADS and PHQ-9.
    Hansson M; Chotai J; Nordstöm A; Bodlund O
    Br J Gen Pract; 2009 Sep; 59(566):e283-8. PubMed ID: 19761655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Generalized Anxiety Disorder Screener (GAD-7) and the anxiety module of the Hospital and Depression Scale (HADS-A) as screening tools for generalized anxiety disorder among cancer patients.
    Esser P; Hartung TJ; Friedrich M; Johansen C; Wittchen HU; Faller H; Koch U; Härter M; Keller M; Schulz H; Wegscheider K; Weis J; Mehnert A
    Psychooncology; 2018 Jun; 27(6):1509-1516. PubMed ID: 29473255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic accuracy of self-rating scales for screening of depression in coronary artery disease patients.
    Bunevicius A; Staniute M; Brozaitiene J; Bunevicius R
    J Psychosom Res; 2012 Jan; 72(1):22-5. PubMed ID: 22200518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validity and Reliability of Screening Measures for Depression and Anxiety Disorders in Rheumatoid Arthritis.
    Hitchon CA; Zhang L; Peschken CA; Lix LM; Graff LA; Fisk JD; Patten SB; Bolton J; Sareen J; El-Gabalawy R; Marriott J; Bernstein CN; Marrie RA
    Arthritis Care Res (Hoboken); 2020 Aug; 72(8):1130-1139. PubMed ID: 31199570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for psychological distress in neurosurgical brain tumor patients using the Patient Health Questionnaire-2.
    Bunevicius A; Deltuva V; Tamasauskas S; Tamasauskas A; Bunevicius R
    Psychooncology; 2013 Aug; 22(8):1895-900. PubMed ID: 23233453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validating screening tools for depression in epilepsy.
    Fiest KM; Patten SB; Wiebe S; Bulloch AG; Maxwell CJ; Jetté N
    Epilepsia; 2014 Oct; 55(10):1642-50. PubMed ID: 25169800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examining the optimal cutoff values of HADS, PHQ-9 and GAD-7 as screening instruments for depression and anxiety in irritable bowel syndrome.
    Snijkers JTW; van den Oever W; Weerts ZZRM; Vork L; Mujagic Z; Leue C; Hesselink MAM; Kruimel JW; Muris JWM; Bogie RMM; Masclee AAM; Jonkers DMAE; Keszthelyi D
    Neurogastroenterol Motil; 2021 Dec; 33(12):e14161. PubMed ID: 33938601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic accuracy of the Patient Health Questionnaire-9 for assessment of depression in type II diabetes mellitus and/or coronary heart disease in primary care.
    van der Zwaan GL; van Dijk SEM; Adriaanse MC; van Marwijk HWJ; van Tulder MW; Pols AD; Bosmans JE
    J Affect Disord; 2016 Jan; 190():68-74. PubMed ID: 26480213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for anxiety and depression in dialysis patients: comparison of the Hospital Anxiety and Depression Scale and the Beck Depression Inventory.
    Preljevic VT; Østhus TB; Sandvik L; Opjordsmoen S; Nordhus IH; Os I; Dammen T
    J Psychosom Res; 2012 Aug; 73(2):139-44. PubMed ID: 22789418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the 10-item Centre for Epidemiological Studies Depression Scale (CES-D-10) in Zulu, Xhosa and Afrikaans populations in South Africa.
    Baron EC; Davies T; Lund C
    BMC Psychiatry; 2017 Jan; 17(1):6. PubMed ID: 28068955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy of the Hospital Anxiety and Depression Scale Depression subscale (HADS-D) to screen for major depression: systematic review and individual participant data meta-analysis.
    Wu Y; Levis B; Sun Y; He C; Krishnan A; Neupane D; Bhandari PM; Negeri Z; Benedetti A; Thombs BD;
    BMJ; 2021 May; 373():n972. PubMed ID: 33972268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of the Depression subscale of the Hospital Anxiety and Depression Scale (HADS-D) for detecting major depression: protocol for a systematic review and individual patient data meta-analyses.
    Thombs BD; Benedetti A; Kloda LA; Levis B; Azar M; Riehm KE; Saadat N; Cuijpers P; Gilbody S; Ioannidis JP; McMillan D; Patten SB; Shrier I; Steele RJ; Ziegelstein RC; Loiselle CG; Henry M; Ismail Z; Mitchell N; Tonelli M
    BMJ Open; 2016 Apr; 6(4):e011913. PubMed ID: 27075844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of the psychometric properties of the Beck Depression Inventory-II, the Montgomery and Åsberg Depression Rating Scale, and the Hospital Anxiety and Depression Scale in a sample from a healthy population.
    Kjaergaard M; Arfwedson Wang CE; Waterloo K; Jorde R
    Scand J Psychol; 2014 Feb; 55(1):83-9. PubMed ID: 24256317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychometric comparison of PHQ-9 and HADS for measuring depression severity in primary care.
    Cameron IM; Crawford JR; Lawton K; Reid IC
    Br J Gen Pract; 2008 Jan; 58(546):32-6. PubMed ID: 18186994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.